These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 7940660)

  • 1. Influence of a 12-hour, 22 degrees C holding period for buffy coats on the preparation of platelet concentrates stored in plasma.
    Boeri N; Saleun S; Pelissier E; Saleun JP; Aiach M; Rendu F
    Transfusion; 1994 Oct; 34(10):881-6. PubMed ID: 7940660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Storage of buffy coat preparations at 22 degrees C in plastic containers with different gas permeability.
    Eriksson L; Eriksson G; Högman CF
    Vox Sang; 1997; 73(2):74-80. PubMed ID: 9304775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of platelet concentrates prepared after two hours and overnight storage of buffy coat at room temperature.
    Ojha S; Tirlotkar A; Gupta AM; S H S; Chavan P; Poojary M
    Transfus Apher Sci; 2021 Feb; 60(1):103014. PubMed ID: 33262053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet quality after 15-day storage of platelet concentrates prepared from buffy coats and stored in a glucose-free crystalloid medium.
    Bertolini F; Rebulla P; Porretti L; Murphy S
    Transfusion; 1992 Jan; 32(1):9-16. PubMed ID: 1731448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of platelet function using the in vitro bleeding time and corrected count increment of transfused platelets. Comparison between platelet concentrates derived from pooled buffy coates and apheresis.
    Eriksson L; Kristensen J; Olsson K; Bring J; Högman CF
    Vox Sang; 1996; 70(2):69-75. PubMed ID: 8801766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of platelet concentrates prepared from buffy coats and stored in a glucose-free crystalloid medium.
    Bertolini F; Rebulla P; Riccardi D; Cortellaro M; Ranzi ML; Sirchia G
    Transfusion; 1989 Sep; 29(7):605-9. PubMed ID: 2773027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Storage of buffy-coat-derived platelets in additive solutions at 4 degrees C and 22 degrees C: flow cytometry analysis of platelet glycoprotein expression.
    Sandgren P; Hansson M; Gulliksson H; Shanwell A
    Vox Sang; 2007 Jul; 93(1):27-36. PubMed ID: 17547562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Storage of buffy coat-derived platelets in additive solutions: in vitro effects of storage at 4 degrees C.
    Sandgren P; Shanwell A; Gulliksson H
    Transfusion; 2006 May; 46(5):828-34. PubMed ID: 16686851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of blood components separated from donated whole blood after an overnight holding at room temperature with the buffy coat method.
    Lu FQ; Kang W; Peng Y; Wang WM
    Transfusion; 2011 Oct; 51(10):2199-207. PubMed ID: 21492181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro evaluation of platelet concentrates, prepared from pooled buffy coats, stored for 8 days after filtration.
    Boomgaard MN; Joustra-Dijkhuis AM; Gouwerok CW; Steneker I; Reesink HW; Loos JA; Pietersz RN; de Korte D
    Transfusion; 1994 Apr; 34(4):311-6. PubMed ID: 8178328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Storage of platelet concentrates from overnight-stored blood and overnight-stored buffy coat: in vitro studies.
    Rácz Z; Baróti C
    Vox Sang; 1995; 68(3):160-3. PubMed ID: 7625072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of holding buffy coats 4 or 18 hours before preparing pooled filtered PLT concentrates in plasma.
    Pérez-Pujol S; Lozano M; Perea D; Mazzara R; Ordinas A; Escolar G
    Transfusion; 2004 Feb; 44(2):202-9. PubMed ID: 14962311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of PGE1 for preparation of platelet concentrates.
    Menitove JE; Frenzke M; Aster RH
    Transfusion; 1986; 26(4):346-50. PubMed ID: 2941906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelets stored in a glucose-free additive solution or in autologous plasma--an ultrastructural and morphometric evaluation.
    Klinger MH; Josch M; Klüter H
    Vox Sang; 1996; 71(1):13-20. PubMed ID: 8837351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Buffy coat platelets stored in apyrase, aprotinin, and ascorbic acid in a suspended bag: combined strategies for reducing platelet activation during storage.
    Mrowiec ZR; Oleksowicz L; Zuckerman D; De Leon-Fernandez M; Khorshidi M; Dutcher JP; Puszkin EG
    Transfusion; 1996 Jan; 36(1):5-10. PubMed ID: 8607153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactions and platelet increments after transfusion of platelet concentrates in plasma or an additive solution: a prospective, randomized study.
    de Wildt-Eggen J; Nauta S; Schrijver JG; van Marwijk Kooy M; Bins M; van Prooijen HC
    Transfusion; 2000 Apr; 40(4):398-403. PubMed ID: 10773049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Storage of platelet concentrates from pooled buffy coats made of fresh and overnight-stored whole blood processed on the novel Atreus 2C+ system: in vitro study.
    Sandgren P; Callaert M; Shanwell A; Gulliksson H
    Transfusion; 2008 Apr; 48(4):688-96. PubMed ID: 18194379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality assessment of platelet concentrates supplemented with second-messenger effectors.
    Rivera J; Lozano ML; Corral J; Connor J; Gónzález-Conejero R; Ferrer F; Currie L; Vicente V
    Transfusion; 1999 Feb; 39(2):135-43. PubMed ID: 10037122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of the time of storage and transfusion reactions to platelet concentrates from buffy coats.
    Riccardi D; Raspollini E; Rebulla P; Pappalettera M; Marangoni F; Greppi N; Sirchia G
    Transfusion; 1997 May; 37(5):528-30. PubMed ID: 9149780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WBC-reduced platelet concentrates from pooled buffy coats in additive solution: an evaluation of in vitro and in vivo measures.
    van der Meer PF; Pietersz RN; Tiekstra MJ; Huijgens PC; Dekker WJ; Reesink HW
    Transfusion; 2001 Jul; 41(7):917-22. PubMed ID: 11452160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.